Literature DB >> 7529909

The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study.

J W Dailey1, D O Seo, Q S Yan, K H Ko, M Jo, P C Jobe.   

Abstract

Loreclezole is an experimental anticonvulsant drug. We found previously that several established anticonvulsants increase extracellular serotonin as measured by microdialysis. We have concluded that the increase in extracellular serotonin and the anticonvulsant effect produced by these anticonvulsant drugs are related in a cause and effect manner. To determine if anticonvulsant doses of loreclezole increase extracellular serotonin, we determined anticonvulsant dose-response relationships in genetically epilepsy-prone rats (GEPRs). Then, we administered ED99 doses of loreclezole to GEPRs and determined the effect on extracellular serotonin as measured by microdialysis in the striatum. We conclude that loreclezole produces a dose-related anticonvulsant effect in GEPRs and that anticonvulsant doses of loreclezole increase extracellular serotonin in these animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529909     DOI: 10.1016/0304-3940(94)90754-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  The genetically epilepsy-prone rat (GEPR).

Authors:  P C Jobe; P K Mishra; L E Adams-Curtis; V U Deoskar; K H Ko; R A Browning; J W Dailey
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

2.  Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.

Authors:  Q S Yan; P C Jobe; J W Dailey
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.